Chronic Kidney Disease (CKD) is diagnosed based on a combined assessment of blood tests, urine tests and imaging studies. Persistent impairment of kidney function for at least three months is a key diagnostic criterion.
Blood analysis
Chronic kidney disease or chronic kidney failure is diagnosed through blood tests that measure creatinine and urea, or BUN, levels as these are the main toxins eliminated by our kidneys. Urine is also analysed to discover the exact volume and composition of urinary output. These results are used to calculate the overall percentage of kidney function (glomerular filtration rate, GFR) which subsequently determines the degree of kidney failure.
The following parameters are evaluated:
Serum creatinine: the primary marker used to estimate kidney function.
Urea or BUN (blood urea nitrogen): this increases when the kidneys are unable to properly eliminate waste products.
Electrolytes: potassium, phosphorus, sodium, and calcium.
Haemoglobin: anaemia is common from the moderate stages of CKD.
Estimated Glomerular Filtration Rate (GFR or eGFR): this is the volume of blood the kidneys filter each minute through the glomeruli (microscopic structures within the kidney), measured in mL/min/1.73 m².
CKD Classification by Glomerular Filtration Rate (KDIGO)
Albuminuria: a key marker of kidney damage; persistent values >30 mg/g are considered pathological.
Urinary sediment: allows identification of haematuria, casts or other abnormalities.
Urine volume measurement: useful for assessing oliguria or polyuria.
Imaging tests
Renal ultrasound is the technique of choice for evaluating kidney size, shape and structure. In selected cases, CT scans or magnetic resonance imaging (MRI) are used.
Kidney biopsy
Indicated when glomerular diseases or immune-mediated lesions are suspected, or when the cause of CKD is unclear. It allows for a precise histological diagnosis.
The importance of early diagnosis
Identifying CKD in stages G1–G3 is essential to prevent disease progression, reduce cardiovascular complications and preserve kidney function for years. In the early stages, symptoms are usually minimal or absent.
Sorry this content wasn't helpful to you. Send us your comment and we will take it into account to continue improving.
Thanks for your help!
An error has occurred and we were unable to send your opinion, please try again later.
Substantiated information by:
Anna YugueroPhysiotherapistNephrology Department
Bárbara Romano AndrioniDietitian - NutritionistEndocrinology and Nutrition Department
Manel Vera RiveraNephrologistNephrology Department
Marta Quintela MartínezNurseNephrology Department
María Teresa López AlonsoNursing of Vascular AccessNephrology Department
Montserrat Monereo FontSocial WorkerNephrology Department
Ángeles Mayordomo SanzPeritoneal Dialysis NurseNephrology Department
Published: 20 February 2018
Updated: 20 February 2018
The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.
Subscribe
Receive the latest updates related to this content.
(*) Mandatory fields
Thank you for subscribing!
If this is the first time you subscribe you will receive a confirmation email, check your inbox
An error occurred and we were unable to send your data, please try again later.